Literature DB >> 30120495

[Intestinal cross-talk : The gut as motor of multiple organ failure].

W Druml1.   

Abstract

The central role of the organ system "gut" for critically ill patients has not been acknowledged until the last decade. The gut is a crucial immunologic, metabolic and neurologic organ system and impairment of its functions is associated with morbidity and mortality. The gut has a central position in the cross-talk between organs and dysfunction of the gut may result in impairment of other intra-abdominal and extra-abdominal organ systems. The intestinal tract is the most important source of endogenous infections and determines the inflammatory status of the organism. Gut failure is an element of the multiple organ dysfunction syndrome (MODS). The leading mechanism in the evolution of endogenous infections is the intestinal translocation of microbes. A dysbiosis and damage of the intestinal mucosa leads to a disorder of the mucosal barrier function, increases the permeability and promotes translocation (leaky gut hypothesis). A further crucial mechanism of organ interactions is the increase in intra-abdominal pressure. Intra-abdominal hypertension promotes further injury of the gut, increases translocation and inflammation and causes dysfunction of other organ systems, such as the kidneys, the cardiovascular system and the lungs. Maintaining and/or restoring intestinal functions must be a priority of any intensive care therapy. The most important measure is early enteral nutrition. Other measures are the preservation of motility and modulation of the intestinal microbiome. Intra-abdominal hypertension must be reduced by an individually adapted infusion therapy, positioning of the patient, administration of drugs (abdominal compliance) and decompression (by tubes, endoscopically or in severe cases surgically).

Entities:  

Keywords:  Bacterial translocation; Enteral nutrition; Intra-abdominal hypertension; Microbiome; Probiotics

Mesh:

Year:  2018        PMID: 30120495     DOI: 10.1007/s00063-018-0475-1

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  43 in total

Review 1.  Abdominal pressure and gastrointestinal function: an inseparable couple?

Authors:  Annika Reintam Blaser; Manu L N G Malbrain; Adrian Regli
Journal:  Anaesthesiol Intensive Ther       Date:  2017-05-17

2.  Early Trophic Enteral Nutrition Is Associated With Improved Outcomes in Mechanically Ventilated Patients With Septic Shock: A Retrospective Review.

Authors:  Jayshil J Patel; Michelle Kozeniecki; Annie Biesboer; William Peppard; Ananda S Ray; Seth Thomas; Elizabeth R Jacobs; Rahul Nanchal; Gagan Kumar
Journal:  J Intensive Care Med       Date:  2014-10-14       Impact factor: 3.510

Review 3.  Should fecal microbial transplantation be used in the ICU?

Authors:  Stephen A McClave; Jayshil Patel; Neal Bhutiani
Journal:  Curr Opin Crit Care       Date:  2018-04       Impact factor: 3.687

4.  Norepinephrine Contributes to Enterocyte Damage in Septic Shock Patients: A Prospective Cohort Study.

Authors:  Quirine L M Habes; Lisa van Ede; Jelle Gerretsen; Matthijs Kox; Peter Pickkers
Journal:  Shock       Date:  2018-02       Impact factor: 3.454

5.  Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial.

Authors:  Evelien A N Oostdijk; Jozef Kesecioglu; Marcus J Schultz; Caroline E Visser; Evert de Jonge; Einar H R van Essen; Alexandra T Bernards; Ilse Purmer; Roland Brimicombe; Dennis Bergmans; Frank van Tiel; Frank H Bosch; Ellen Mascini; Arjanne van Griethuysen; Alexander Bindels; Arjan Jansz; Fred A L van Steveninck; Wil C van der Zwet; Jan Willem Fijen; Steven Thijsen; Remko de Jong; Joke Oudbier; Adrienne Raben; Eric van der Vorm; Mirelle Koeman; Philip Rothbarth; Annemieke Rijkeboer; Paul Gruteke; Helga Hart-Sweet; Paul Peerbooms; Lex J Winsser; Anne-Marie W van Elsacker-Niele; Kees Demmendaal; Afke Brandenburg; Anne Marie G A de Smet; Marc J M Bonten
Journal:  JAMA       Date:  2014-10-08       Impact factor: 56.272

6.  Dietary Supplementation With Nonfermentable Fiber Alters the Gut Microbiota and Confers Protection in Murine Models of Sepsis.

Authors:  Michael J Morowitz; Valentina Di Caro; Diana Pang; Jessica Cummings; Brian Firek; Matthew B Rogers; Sarangarajan Ranganathan; Robert S B Clark; Rajesh K Aneja
Journal:  Crit Care Med       Date:  2017-05       Impact factor: 7.598

7.  Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis.

Authors:  Muhittin Tasdogan; Dilek Memis; Necdet Sut; Mahmut Yuksel
Journal:  J Clin Anesth       Date:  2009-09       Impact factor: 9.452

8.  Fecal microbiota transplantation for multiple organ dysfunction syndrome.

Authors:  Nathan J Klingensmith; Craig M Coopersmith
Journal:  Crit Care       Date:  2016-12-19       Impact factor: 9.097

Review 9.  Role of the microbiome, probiotics, and 'dysbiosis therapy' in critical illness.

Authors:  Paul E Wischmeyer; Daniel McDonald; Rob Knight
Journal:  Curr Opin Crit Care       Date:  2016-08       Impact factor: 3.687

10.  The role of intestinal mucosa injury induced by intra-abdominal hypertension in the development of abdominal compartment syndrome and multiple organ dysfunction syndrome.

Authors:  Juntao Cheng; Zhiyi Wei; Xia Liu; Ximei Li; Zhiqiang Yuan; Jiang Zheng; Xiaodong Chen; Guangxia Xiao; Xiaoyi Li
Journal:  Crit Care       Date:  2013-12-09       Impact factor: 9.097

View more
  3 in total

1.  Rhubarb-Aconite Decoction (RAD) Drug-Containing Serum Alleviated Endotoxin-Induced Oxidative Stress Injury and Inflammatory Response in Caco-2 Cells In Vitro.

Authors:  Xiao-Hong Du; Qing-Jun Chen; Jian-Bo Song; Yan Xie; Yan Zhi; Ru-Ru Sun; Guo-Hui Liu; Xin Kang
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-04       Impact factor: 2.629

Review 2.  Systemic inflammatory response syndrome is triggered by mitochondrial damage (Review).

Authors:  Can Kong; Wei Song; Tao Fu
Journal:  Mol Med Rep       Date:  2022-03-02       Impact factor: 2.952

3.  miR-125b-5p inhibits cell proliferation by targeting ASCT2 and regulating the PI3K/AKT/mTOR pathway in an LPS-induced intestinal mucosa cell injury model.

Authors:  Huiming Guo; Jianyuan Gao; Yuan Qian; Huawei Wang; Jiang Liu; Qingyan Peng; Yong Zhou; Kunhua Wang
Journal:  Exp Ther Med       Date:  2021-06-06       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.